U6 is not a suitable endogenous control for the quantification of circulating microRNAs

Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev. Cell, 11, 441, 10.1016/j.devcel.2006.09.009 Stefani, 2008, Small non-coding RNAs in animal development, Nat. Rev. Mol. Cell Biol., 9, 219, 10.1038/nrm2347 Lee, 2009, MicroRNAs in cancer, Annu. Rev. Pathol., 4, 199, 10.1146/annurev.pathol.4.110807.092222 Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc. Natl. Acad. Sci. U.S.A., 105, 10513, 10.1073/pnas.0804549105 Chen, 2008, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res., 18, 997, 10.1038/cr.2008.282 Sanders, 2012, Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma, Int. J. Urol., 19, 1017, 10.1111/j.1442-2042.2012.03082.x Chen, 2012, A panel of five circulating microRNAs as potential biomarkers for prostate cancer, Prostate, 72, 1443, 10.1002/pros.22495 Adam, 2013, Plasma microRNA profiles for bladder cancer detection, Urol. Oncol., 31, 1701, 10.1016/j.urolonc.2012.06.010 Tsujiura, 2010, Circulating microRNAs in plasma of patients with gastric cancers, Br. J. Cancer, 102, 1174, 10.1038/sj.bjc.6605608 Resnick, 2009, The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform, Gynecol. Oncol., 112, 55, 10.1016/j.ygyno.2008.08.036 Bryant, 2012, Changes in circulating microRNA levels associated with prostate cancer, Br. J. Cancer, 106, 768, 10.1038/bjc.2011.595 Miah, 2012, An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer, Br. J. Cancer, 107, 123, 10.1038/bjc.2012.221 Wang, 2012, Expression of microRNAs in the urine of patients with bladder cancer, Clin. Genitourin. Cancer, 10, 106, 10.1016/j.clgc.2012.01.001 Lawrie, 2008, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma, Br. J. Haematol., 141, 672, 10.1111/j.1365-2141.2008.07077.x Heneghan, 2010, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, Ann. Surg., 251, 499, 10.1097/SLA.0b013e3181cc939f Huang, 2010, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, Int. J. Cancer, 127, 118, 10.1002/ijc.25007 Wang, 2009, MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease, Cancer Prev. Res. (Phila), 2, 807, 10.1158/1940-6207.CAPR-09-0094 Wong, 2008, Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue, Clin. Cancer Res., 14, 2588, 10.1158/1078-0432.CCR-07-0666 Redova, 2012, Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma, J. Transl. Med., 10, 55, 10.1186/1479-5876-10-55 Watahiki, 2013, Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer, Int. J. Mol. Sci., 14, 7757, 10.3390/ijms14047757 Vasilescu, 2009, MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis, PLoS ONE, 4, e7405, 10.1371/journal.pone.0007405 Tanaka, 2009, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients, PLoS ONE, 4, e5532, 10.1371/journal.pone.0005532 Von, 2012, MicroRNA 15a, inversely correlated to PKCalpha, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples, Am. J. Pathol., 180, 1787, 10.1016/j.ajpath.2012.01.014 Zhao, 2013, Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma, Exp. Mol. Pathol., 94, 115, 10.1016/j.yexmp.2012.10.005 Zhu, 2009, Circulating microRNAs in breast cancer and healthy subjects, BMC Res. Notes, 2, 89, 10.1186/1756-0500-2-89 Reid, 2011, Circulating microRNAs: association with disease and potential use as biomarkers, Crit. Rev. Oncol. Hematol., 80, 193, 10.1016/j.critrevonc.2010.11.004 Ho, 2010, Circulating miR-210 as a novel hypoxia marker in pancreatic cancer, Transl. Oncol., 3, 109, 10.1593/tlo.09256 Wang, 2010, Serum miR-146a and miR-223 as potential new biomarkers for sepsis, Biochem. Biophys. Res. Commun., 394, 184, 10.1016/j.bbrc.2010.02.145 Brase, 2011, Circulating miRNAs are correlated with tumor progression in prostate cancer, Int. J. Cancer, 128, 608, 10.1002/ijc.25376 Selth, 2012, Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease, Int. J. Cancer, 131, 652, 10.1002/ijc.26405 Nguyen, 2013, Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer, Prostate, 73, 346, 10.1002/pros.22572 Hauser, 2012, Analysis of serum microRNAs (miR-26a-2∗, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma, Cancer Epidemiol., 36, 391, 10.1016/j.canep.2012.04.001 Hu, 2010, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer, J. Clin. Oncol., 28, 1721, 10.1200/JCO.2009.24.9342 Liu, 2011, A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis, Eur. J. Cancer, 47, 784, 10.1016/j.ejca.2010.10.025 Chim, 2008, Detection and characterization of placental microRNAs in maternal plasma, Clin. Chem., 54, 482, 10.1373/clinchem.2007.097972 Heneghan, 2010, Circulating miRNA signatures: promising prognostic tools for cancer, J. Clin. Oncol., 28, e573, 10.1200/JCO.2010.29.8901 Zeng, 2012, Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma, PLoS ONE, 7, e46367, 10.1371/journal.pone.0046367 Wylie, 2011, A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data, BMC Res. Notes, 4, 555, 10.1186/1756-0500-4-555 Koberle, 2013, Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers, PLoS ONE, 8, e75184, 10.1371/journal.pone.0075184 Squadrito, 2014, Endogenous RNAs modulate MicroRNA sorting to exosomes and transfer to acceptor cells, Cell Rep., 8, 1432, 10.1016/j.celrep.2014.07.035 Pegtel, 2014, Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain, Philos. Trans. R. Soc. Lond. B Biol. Sci., 369, 10.1098/rstb.2013.0516 Suetsugu, 2013, Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models, Adv. Drug Deliv. Rev., 65, 383, 10.1016/j.addr.2012.08.007 Hessvik, 2013, Exosomal miRNAs as biomarkers for prostate cancer, Front. Genet., 4, 36, 10.3389/fgene.2013.00036